KOL Identification and Mapping for Healthcare

Because of our in-house panel, we are the most trusted partner in identifying, mapping, and engaging KOLs in the healthcare industry.

Healthcare key Opinion Leaders

Because their recommendations on pharmaceuticals and devices are founded on solid research, key opinion leaders(KOL) are the perfect drivers for any healthcare product firm (drugs, gadgets, diagnostics).

At SGA, we work with our customers to find the kind of key opinion leader (KOL) to advise them on the best ways to network within their business. It can result in a more extensive disease environment within which the client’s treatment or technology must function.

Generative AI Development
What Difference Does SGA Make with its

KOL Mapping Services for the Healthcare Industry

SGA’s panel of KOLs spans more than 30 sub-specialties and 15 organizational levels, from chief executive officers to senior managers and distributors. Our panelists provide invaluable insight into the market’s mood, perspective, and anticipations throughout a client’s product’s lifetime and clinical trials. Our bilingual analysts will facilitate communication with these key opinion leaders in both English- and non-English-speaking areas.

Why SGA

Industry Leader

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Medical Devices

We support new product entries, competitive intelligence (CI), and market intelligence teams with relevant information.

Pharmaceuticals & Biopharma

We support pharma and biopharma market intelligence, strategy, sales, marketing, and R&D teams in developed and developing markets.

Mergers and Acquisition Analysis

We support M&A firms with product portfolio fitment analysis, patents and clinical trial data, pipeline analysis, and short listing of healthcare acquirer and acquire prospects.

Private Equity, Investment Banks, and Investor Community

We support financial firms with ad-hoc and white-labeled research comprising industry analysis, primary research, and CI intel from major markets.

Animal Health

We offer market intelligence on veterinary products and equipment and help mid-senior management with relevant data.

In Vitro Diagnostics

We track diagnostics kits, reagents, and equipment, which help marketing and sales teams with market penetration efforts. Our services are preferred by product managers and marketing leaders.

Life Sciences & Healthcare IT

We offer technology tracking services, market sizing and forecasting, and primary market research involving healthcare payers and providers and product launch information to life sciences & healthcare IT leaders of the world.

Life Sciences Consulting & Information Service Providers

We have run off-shored capability centers of ISPs, with a record of tracking >5,000 pharmaceutical companies and supporting their onshore teams to track markets and create analyses.

Our Ins(AI)ghts

Whitepaper

Healthcare Market Research in the Era of New Technology

As healthcare systems grow more complex, traditional research approaches face limitations in capturing real-time trends and patient behavior. This whitepaper explores how emerging technologies—like AI, machine learning, and synthetic data—are redefining healthcare market research. From improving predictive modeling to enhancing patient segmentation, these innovations are enabling faster, more accurate insights. Learn how forward-thinking healthcare organizations are modernizing their research frameworks to stay ahead of dynamic market shifts and deliver value-driven outcomes in a tech-powered era.

Read More

BLOG

Healthcare Industry Trends to Watch Out for in 2025

The global healthcare industry is entering a transformative era in 2025, driven by innovation, strategic investments, and evolving market dynamics. The industry is poised for growth across key submarkets like HealthTech, MedTech, and Pharmatech. A Deloitte Center for Health Solutions survey reveals that nearly 60% of industry leaders have a positive outlook for 2025, up from 52% the previous year. According to Bain & Company, the global healthcare private equity (PE) deal activity reached an estimated $115 billion in 2024, marking the second-highest deal value on record, driven by a surge in large-scale deals.

Read More
Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labeled research coverage.